首頁 > 市場調查報告書 > 工業機械

測量儀器生技設備

市場調查報告書

商品編碼

1775461

實驗室設備市場：2025-2030 年預測

Lab Equipment Market - Forecasts from 2025 to 2030

出版日期: 2025年06月30日 | 出版商:

Knowledge Sourcing Intelligence | 英文 150 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

實驗室設備市場預計將從 2025 年的 195.07 億美元成長到 2030 年的 273.1 億美元，複合年成長率為 6.96%。

加大對醫藥研發的投入

製藥公司正在大幅加大研發投入以應對慢性疾病，這為實驗室器具市場創造了巨大的商機。根據產業報告顯示，2024 年全球醫藥品研究開發費用將達到 2,800 億美元，重點在於開發創新藥物和生技藥品。政府舉措正在透過簡化臨床試驗流程進一步加速這一趨勢。例如，歐洲藥品管理局於 2023 年引入了快速通道系統，將基因和細胞治療試驗的核准時間從 25 天縮短至 30 天，使公司能夠優先考慮藥物開發。活性化推動了對光譜儀、攪拌機和電導率計等先進實驗室器具的需求，這些器具對於藥物發現和測試至關重要。

慢性病盛行率上升

癌症、糖尿病和心血管疾病等慢性病負擔的加重是市場成長的主要驅動力。根據美國衛生與美國服務部的數據，2024 年美國將診斷出超過 190 萬例新癌症病例，導致約 61 萬人死亡，癌症成為第二大死因。此外，約有 3,800 萬美國人患有糖尿病，這增加了心臟病和腎衰竭的風險。這些疾病需要先進的診斷和藥物開發，從而推動了對支持有效治療方法研究的實驗室儀器的需求。全球範圍內慢性病的增加，尤其是老齡化人口的增加，進一步推動了對尖端檢測工具的需求。

生技藥品需求不斷成長

生技藥品，對市場成長做出了巨大貢獻。根據世界衛生組織（WHO）國際臨床註冊平台的數據，到2024年，生技藥品將佔據藥品研發線的很大一部分，全球整體將集中於此類治療。生技藥品針對癌症和自體免疫疾病等常見疾病，需要專門的實驗室設備進行開發和測試。由於生技藥品的療效和日益成長的消費者需求，生技藥品研究蓬勃發展，這推動了對先進測試工具的需求，從而進一步刺激市場擴張。

市場區隔分析

按類型

實驗室儀器市場細分為具有樣品特性感測功能的儀器（光譜儀、電導率儀等）及不具樣品特性感測功能的儀器（攪拌機、加熱爐等）。感測領域佔據主導地位，因為它在精準診斷和藥物開發中發揮著至關重要的作用，尤其是在生技藥品和慢性病研究中。

按最終用戶

市場細分為政府、生物製藥、工業和其他終端用戶。生物製藥領域在2024年佔據最大佔有率，這得益於高額研發投入和藥物研發對專用設備的需求。政府機構和學術研究機構也是主要貢獻者，並得到了公共醫療研究資金的支持。

地理洞察力

由於先進的醫療基礎設施和美國領先的生物製藥公司，北美佔據了重要的市場佔有率。 2024年，該地區將佔據全球實驗室用具收益的35%以上，這得益於其強大的研發生態系統。由於慢性病發病率上升以及中國和印度等國家醫藥投資的增加，亞太地區成長最快。例如，印度2024年的醫療保健預算已撥款150億美元用於研發，這將刺激對實驗室用具的需求。緊隨其後的是歐洲，由於監管部門對創新治療方法的支持，該地區也將迎來強勁成長。

競爭考察

艾本德（Eppendorf AG）、羅氏公司（F. Hoffmann-La Roche Ltd）、安捷倫科技公司（Agilent Technologies, Inc.）和賽默飛世爾科技公司（Thermo Fisher Scientific Inc.）等主要企業憑藉其強大的品牌聲譽和創新產品佔據市場主導地位。 2023年，賽默飛世爾科技推出了專為生技藥品研究量身定做的先進光譜儀器，以提高藥物開發的精確度。安捷倫於2024年推出自動化實驗室解決方案，以提高高通量測試的效率。這些公司利用策略性收購和研發投資來維持市場領先地位。

市場挑戰

先進實驗室設備的高成本以及對操作複雜系統的熟練人員的需求構成了挑戰，尤其是在發展中地區。此外，臨床試驗設備嚴格的監管要求可能會減緩其市場准入速度，並迫使其持續創新以滿足合規標準。

本報告的主要優點

深刻分析：獲得涵蓋主要和新興地區的深入市場洞察，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、垂直行業和其他細分市場。
競爭格局：了解主要企業採用的策略策略，並了解正確策略的市場滲透潛力。
市場趨勢和促進因素：探索動態因素和關鍵市場趨勢以及它們將如何影響市場的未來發展。
可行的建議：利用洞察力進行策略決策並在動態環境中發現新的業務來源和收益。
受眾範圍廣：對於新興企業、研究機構、顧問、中小企業和大型企業來說都是有益且具成本效益的。

它有什麼用途？

產業與市場考量、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本支出決策、法律規範與影響、新產品開發、競爭影響

研究範圍

2022 年至 2024 年的實際數據和 2025 年至 2030 年的預測數據
成長機會、挑戰、供應鏈前景、法律規範與趨勢分析
競爭定位、策略和市場佔有率分析
收益成長和預測細分市場和區域分析（包括國家）
公司概況（策略、產品、財務、主要發展等）

介紹
北美洲
- 按類型
- 按最終用戶
- 按國家
  - 美國
  - 加拿大
  - 墨西哥
南美洲
- 按類型
- 按最終用戶
- 按國家
  - 巴西
  - 阿根廷
  - 其他
歐洲
- 按類型
- 按最終用戶
- 按國家
  - 英國
  - 德國
  - 法國
  - 西班牙
  - 其他
中東和非洲
- 按類型
- 按最終用戶
- 按國家
  - 沙烏地阿拉伯
  - 阿拉伯聯合大公國
  - 其他
亞太地區
- 按類型
- 按最終用戶
- 按國家
  - 中國
  - 日本
  - 印度
  - 韓國
  - 台灣
  - 其他

第8章競爭格局及分析

主要企業和策略分析
市場佔有率分析
合併、收購、協議和合作
競爭對手儀表板

第9章：公司簡介

Eppendorf AG
Beckman Coulter, Inc.
Agilent Technologies, Inc.
Thermo Fisher Scientific Inc.
Waters Corporation
F. Hoffmann-La Roche Ltd
Shimadzu Corporation
Bio-Rad Laboratories, Inc.
PerkinElmer Inc.

第10章附錄

貨幣
先決條件
基準年和預測年時間表
相關人員的主要利益
調查方法
簡稱

簡介目錄

Product Code: KSI061613570

The Lab Equipment Market is expected to grow from USD 19.507 billion in 2025 to USD 27.310 billion in 2030, at a CAGR of 6.96%.

Increasing Investments in Pharmaceutical R&D

Pharmaceutical companies are significantly boosting R&D investments to address chronic diseases, creating substantial opportunities for the lab equipment market. In 2024, global pharmaceutical R&D spending reached USD 280 billion, with a focus on developing innovative drugs and biologics, according to industry reports. Government initiatives are further accelerating this trend by streamlining clinical trial processes. For instance, in 2023, the European Medicines Agency introduced fast-track schemes reducing approval times for gene and cell therapy trials by 25-30 days, enabling companies to prioritize drug development. This heightened R&D activity drives demand for advanced lab equipment, such as spectrometers, mixers, and conductivity meters, essential for drug discovery and testing.

Rising Prevalence of Chronic Diseases

The growing burden of chronic diseases, including cancer, diabetes, and cardiovascular conditions, is a key driver of market growth. In the United States, over 1.9 million new cancer cases were diagnosed in 2024, with approximately 610,000 deaths, making it the second leading cause of mortality, per the U.S. Department of Health and Human Services. Additionally, around 38 million Americans live with diabetes, increasing risks of heart disease and kidney failure. These conditions necessitate advanced diagnostics and drug development, boosting demand for lab equipment to support research into effective treatments. The global rise in chronic diseases, particularly in aging populations, further amplifies the need for cutting-edge laboratory tools.

Growing Demand for Biologics

The increasing popularity of biologics-drugs derived from living organisms-is significantly contributing to market growth. In 2024, biologics accounted for a substantial portion of the pharmaceutical pipeline, with 40% of clinical trials globally focused on these therapies, according to the World Health Organization's International Clinical Registry Platform. Biologics target prevalent diseases like cancer and autoimmune disorders, requiring specialized lab equipment for development and testing. This surge in biologics research, driven by their efficacy and growing consumer demand, is propelling the need for advanced laboratory tools, further fueling market expansion.

Market Segmentation Analysis

By Type

The lab equipment market is segmented into equipment with sample characteristic sensing (e.g., spectrometers, conductivity meters) and without sample characteristic sensing (e.g., mixers, furnaces). The sensing segment dominates due to its critical role in precise diagnostics and drug development, particularly for biologics and chronic disease research.

By End-User

The market is classified into government, biopharmaceutical, industrial, and other end-users. The biopharmaceutical segment held the largest share in 2024, driven by heavy R&D investments and the need for specialized equipment in drug discovery. Government and academic research institutions are also significant contributors, supported by public funding for health research.

Geographical Insights

North America holds a significant market share, driven by advanced healthcare infrastructure and the presence of major biopharmaceutical companies in the U.S. In 2024, the region accounted for over 35% of global lab equipment revenue, bolstered by robust R&D ecosystems. The Asia-Pacific region is the fastest-growing, fueled by rising chronic disease prevalence and increasing pharmaceutical investments in countries like China and India. For instance, India's 2024 healthcare budget allocated USD 15 billion for R&D, enhancing lab equipment demand. Europe follows, with strong growth driven by regulatory support for innovative therapies.

Competitive Insights

Key players, including Eppendorf AG, F. Hoffmann-La Roche Ltd, Agilent Technologies, Inc., and Thermo Fisher Scientific Inc., dominate the market due to their strong brand reputation and innovative product offerings. In 2023, Thermo Fisher launched advanced spectrometry equipment tailored for biologics research, enhancing precision in drug development. Agilent introduced automated lab solutions in 2024, improving efficiency in high-throughput testing. These companies are leveraging strategic acquisitions and R&D investments to maintain market leadership.

Market Challenges

High costs of advanced lab equipment and the need for skilled personnel to operate complex systems pose challenges, particularly in developing regions. Additionally, stringent regulatory requirements for equipment used in clinical trials can delay market entry, requiring continuous innovation to meet compliance standards.

Key Benefits of this Report:

Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Historical data from 2022 to 2024 & forecast data from 2025 to 2030
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Lab Equipment Market Segmentation

By Type

Analytical Instruments
General Lab Equipment
Measuring & Monitoring Devices
Specialty Equipment
Support Equipment

By End-User

Academic & Research Institutes
Biopharmaceutical & Pharmaceutical Companies
Healthcare & Diagnostic Labs
Government & Regulatory Bodies
Industrial & Manufacturing
Others

By Geography

North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
Germany
France
United Kingdom
Spain
Italy
Others
Middle East and Africa
Saudi Arabia
Israel
Others
Asia Pacific
China
Japan
South Korea
India
Indonesia
Thailand
Others

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation

3. BUSINESS LANDSCAPE

3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter's Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL LAB EQUIPMENT MARKET BY TYPE

5.1. Introduction
5.2. Analytical Instruments
5.3. General Lab Equipment
5.4. Measuring & Monitoring Devices
5.5. Specialty Equipment
5.6. Support Equipment

6. GLOBAL LAB EQUIPMENT MARKET BY END-USER

6.1. Introduction
6.2. Academic & Research Institutes
6.3. Biopharmaceutical & Pharmaceutical Companies
6.4. Healthcare & Diagnostic Labs
6.5. Government & Regulatory Bodies
6.6. Industrial & Manufacturing
6.7. Others

7. GLOBAL LAB EQUIPMENT MARKET BY GEOGRAPHY

7.1. Introduction
7.2. North America
- 7.2.1. By Type
- 7.2.2. By End-User
- 7.2.3. By Country
  - 7.2.3.1. USA
  - 7.2.3.2. Canada
  - 7.2.3.3. Mexico
7.3. South America
- 7.3.1. By Type
- 7.3.2. By End-User
- 7.3.3. By Country
  - 7.3.3.1. Brazil
  - 7.3.3.2. Argentina
  - 7.3.3.3. Others
7.4. Europe
- 7.4.1. By Type
- 7.4.2. By End-User
- 7.4.3. By Country
  - 7.4.3.1. United Kingdom
  - 7.4.3.2. Germany
  - 7.4.3.3. France
  - 7.4.3.4. Spain
  - 7.4.3.5. Others
7.5. Middle East and Africa
- 7.5.1. By Type
- 7.5.2. By End-User
- 7.5.3. By Country
  - 7.5.3.1. Saudi Arabia
  - 7.5.3.2. UAE
  - 7.5.3.3. Others
7.6. Asia Pacific
- 7.6.1. By Type
- 7.6.2. By End-User
- 7.6.3. By Country
  - 7.6.3.1. China
  - 7.6.3.2. Japan
  - 7.6.3.3. India
  - 7.6.3.4. South Korea
  - 7.6.3.5. Taiwan
  - 7.6.3.6. Others